Cell Signaling Technology

Cyclophilin B (D1V5J) Rabbit Monoclonal Antibody

#43603 · $173,351

68
Citing papers
3.1k
Combined citations
Supplier page Find this product

Research areas

Retinal Diseases and Treatments14Mast cells and histamine8Bone health and treatments7Advanced Glycation End Products research7PI3K/AKT/mTOR signaling in cancer5Immune cells in cancer5Immune Response and Inflammation4Connexins and lens biology3

Papers citing this product

1
An amino-bisphosphonate targets MMP-9–expressing macrophages and angiogenesis to impair cervical carcinogenesis
Journal of Clinical Investigation·2004·609 cit.·DOI
2
An amino-bisphosphonate targets MMP-9–expressing macrophages and angiogenesis to impair cervical carcinogenesis
Journal of Clinical Investigation·2004·576 cit.·DOI
3
NRF2 plays a protective role in diabetic retinopathy in mice
Diabetologia·2013·208 cit.·DOI
4
Akt Is a Downstream Target of NF-κB
Journal of Biological Chemistry·2002·193 cit.·DOI
5
Flavonoid Naringenin Attenuates Oxidative Stress, Apoptosis and Improves Neurotrophic Effects in the Diabetic Rat Retina
Nutrients·2017·143 cit.·DOI
6
FOXO1 Plays an Important Role in Enhanced Microvascular Cell Apoptosis and Microvascular Cell Loss in Type 1 and Type 2 Diabetic Rats
Diabetes·2009·135 cit.·DOI
7
Mechanisms of modified LDL-induced pericyte loss and retinal injury in diabetic retinopathy
Diabetologia·2012·129 cit.·DOI
8
The Integrin Antagonist Cilengitide Activates αVβ3, Disrupts VE-Cadherin Localization at Cell Junctions and Enhances Permeability in Endothelial Cells
PLoS ONE·2009·126 cit.·DOI
9
Development of a pentavalent broadly protective nucleoside-modified mRNA vaccine against influenza B viruses
Nature Communications·2022·83 cit.·DOI
10
Nrf2 Activation Is a Potential Therapeutic Approach to Attenuate Diabetic Retinopathy
Investigative Ophthalmology & Visual Science·2018·72 cit.·DOI

Rate this reagent

Used this in your lab? Leave a quick rating. Reviews are anonymous and verified by academic email before they appear.

Your email is never shown publicly.